Screener
Beam Therapeutics BEAM Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Beam Therapeutics’s 10-Q, filed November 4, 2025. Open the filing →
- Filed
- Nov 4, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-263542
FAQ
- What is Beam Therapeutics's return on equity?
- Beam Therapeutics (BEAM) reported return on equity of -47.1% in Q3 2025.
- What is the long-term trend for Beam Therapeutics's return on equity?
- Over 2 years (2021 to 2024), Beam Therapeutics's return on equity has grown at a -20.3% compound annual growth rate (CAGR), from -69.1% to -43.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Beam Therapeutics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude